April Journal-2009.p65 - Association of Biotechnology and Pharmacy

Current Trends in Biotechnology and Pharmacy
Vol. 3 (2) 138-148, April 2009. ISSN 0973-8916
146
Government of India, India, and Department of
Atomic Energy (BNRS), for financial support to
perform this work. We thank Dr. H.N. Yejurvedi,
In-charge, animal facility, Department of Zoology,
University of Mysore for providing animals for
the experiment.
References
1. Srinivasan, S., Ranga, R.S., Burikihanov, R.,
Han, S.S. and Chendil, D. (2007). Par-4-
Dependent Apoptosis by the Dietary
Compound Withaferin A in Prostate Cancer
Cells. Cancer Research, 67: 246-53.
2. Malik, F., Kumar, A., Bhushan, S., Khan,
S., Bhatia, A., Suri, K.A., Qazi, G.N. and
Singh, J. (2007). Reactive oxygen species
generation and mitochondrial dysfunction in
the apoptotic cell death of human myeloid
leukemia HL-60 cells by a dietary compound
withaferin A with concomitant protection by
N-acetyl cysteine. Apoptosis, 12:2115-2133.
3. Sen, N., Banerjee, B., Das, B.B., Ganguly,
A., Sen, T., Pramanik, S., Mukhopadhyay,
S. and Majumder, H.K. (2007). Apoptosis
is induced in leishmanial cells by a novel
protein kinase inhibitor withaferin A and is
facilitated by apoptotic topoisomerase I-
DNA complex. Cell Death and
Differentiation, 14: 358-367.
4. Mohan, R., Hammers, H.J., Mohan, P.B.,
Zhan, X.H., Herbstritt, C.J., Ruiz, A., Zhang,
L., Hanson, A.D., Conner, B.P., Rougas, J.
and Pribluda, V.S. (2004). Withaferin A is
a potent inhibitor of angiogenesis.
Angiogenesis, 7: 115-122.
5. Liotta, L.A., Steeg, P.S. and Stetler-
Stevenson, W.G. (1991). Cancer metastasis
and angiogenesis: an imbalance of positive
and negative regulation. Cell, 64: 327-336.
6. Bhattacharya, S.K., Satyan, K.S. and
Ghosal, S. (1997). Antioxidant activity of
glycowithanolides from W somnifera in rat
Sp1 transcription factor
brain frontal cortex and striatum. Indian
Journal of Experimental Biology, 35: 236-
239.
7. Bhattacharya, A., Ghosal, S. and
Bhattacharya, S.K. (2001). Anti-oxidant
effect of Withania somnifera
glycowithanolides in chronic footshock
stress-induced perturbations of oxidative
free radical scavenging enzymes and lipid
peroxidation in rat frontal cortex and
striatum. Journal of Ethnopharmacology, 74:
1-6.
8. Mishra, L.C., Singh, B.B. and Dagenais, S.
(2000). Scientific basis for the therapeutic
use of Withania somnifera (Ashwagandha):
a review. Alternative Medicine Review, 5:
334-346.
9. Upton, R. (2000). American Herbal
Pharmacopoeia and Therapeutic
Compendium: Ashwagandha Root
(Withania somnifera) - Standards of
Analysis, Quality Control, and Therapeutics.
Santa Cruz, California.
10. Forsythe, J.A., Jiang, B.H., Iyer, N.V.,
Agani, F., Leung, S.W., Koos, R.D. and
Semenza, G.L. (1996). Activation of vascular
endothelial growth factor gene transcription
by hypoxia-inducible factor 1. Molecular
and Cellular Biology, 16: 4604-4613.
11. Feldser, D., Agani, F., Iyer, N.V., Pak, B.,
Ferreira, G. and Semenza, G.L. (1999).
Reciprocal positive regulation of hypoxiainducible
factor 1alpha and insulin-like
growth factor 2. Cancer Research, 59: 3915-
3918.
12. Tischer, E., Mitchell, R., Hartman, T., Silva,
M., Gospodarowicz, D., Fiddes, J.C. and
Abraham, J.A. (1991). The human gene for
vascular endothelial growth factor. Multiple
protein forms are encoded through
alternative exon splicing. Journal of
Biological Chemistry, 266: 11947-11954.